← Back to all trials
Completed
NCT05716308
The Effect Evaluation of Continuous Nursing Intervention in Patients With Type 2 Diabetic Retinopathy
Conditions: Type 2 Diabetic Retinopathy
Sex: All
Healthy volunteers: 1
Phase: NA
Enrollment: 100
Sponsor: Beijing Tongren Hospital
Location: China
Summary
Objective: To evaluate the application effect of continuous nursing intervention in type 2 diabetic retinopathy (DR), and to explore its clinical application value.
Methods：Patients with type 2 DR admitted to our Hospital from June 2019 to June 2022 were selected as the research objects and divided into intervention group and control group by random number table method.
The control group received routine nursing intervention, and the intervention group received continuous nursing intervention on the basis of the control group.
The related effect evaluation indexes such as fasting blood glucose, 2-hour postprandial blood glucose, glycosylated hemoglobin and visual acuity were collected and compared between the two groups at discharge, 1 year and 2 years after discharge.
The readmission rate of the two groups was counted to evaluate the effect of continuous nursing intervention.
Eligibility Criteria
Inclusion Criteria:(1) DR diagnosis and classification criteria in line with the latest version of the 2017 Clinical Guidelines for Diabetic Retinopathy developed by the American Eye Association [9];(2) Type 2 diabetes course of more than 5 years, with varying degrees of retinopathy;(3) Monocular disease, no blindness;(4) Education level above primary school; - (5) Patients informed consent for this study and signed a consent form.Exclusion Criteria:(1) with severe cerebral hemorrhage or cerebral infarction, severe nephrotic syndrome, senile dementia, cardiovascular and cerebrovascular diseases;(2) Patients with macular edema, severe corneal (and) or lens opacity affect the observation of the fundus, angle-closure glaucoma can not mydriasis, other fundus diseases, and nursing interventions for other chronic diseases.
This study was approved by the ethics committee of our hospital.
Source: ClinicalTrials.gov (NCT05716308). StuddyBuddy aggregates publicly available trial information.
